Integrated Advisors Network LLC Moderna, Inc. Transaction History

Integrated Advisors Network LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$101.21 - $166.61 $11,436 - $18,826	-113 Reduced 5.48%	1,948 $231,000
Q1 2024 May 03, 2024	BUY	$85.37 - $115.44 $175,947 - $237,921	2,061 New	2,061 $219,000
Q2 2023 Jul 14, 2023	BUY	$118.5 - $160.53 $5,451 - $7,384	46 Added 2.3%	2,046 $248,000
Q1 2023 May 05, 2023	SELL	$135.66 - $197.02 $581,981 - $845,215	-4,290 Reduced 68.2%	2,000 $307,000
Q4 2022 Feb 02, 2023	BUY	$118.38 - $210.04 $744,610 - $1.32 Million	6,290 New	6,290 $1.13 Million
Q3 2022 Nov 07, 2022	BUY	$118.07 - $194.18 $2,125 - $3,495	18 Added 1.05%	1,726 $204,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $20,146 - $30,373	172 Added 11.2%	1,708 $244,000
Q1 2022 May 02, 2022	SELL	$126.46 - $235.05 $49,572 - $92,139	-392 Reduced 20.33%	1,536 $265,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $83,327 - $135,980	-369 Reduced 16.06%	1,928 $490,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $245,421 - $535,823	1,106 Added 92.86%	2,297 $884,000
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $154,722 - $279,861	1,191 New	1,191 $280,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Advisors Network LLC with notifications on news.